Spinal Tech

Zimmer Posts $1.12B in Q1 Net Sales, 5% Increase

Zimmer Holdings has reported first quarter FY 2011 net sales of $1.12 billion, representing an increase of 5.0 percent compared to the first quarter of FY 2010, according to a company news release.

MiMedx Q1 Revenues Up Following Surgical Biologics Acquisition

MiMedx, a developer of biomaterial-based products and bioimplants, has posted $1.04 million in total revenue for the first quarter of FY 2011, representing an 808 percent increase compared to $114,900 in revenue for the first quarter of last year, according…

Medtronic Cuts 268 Jobs in Minnesota, Blames Sluggish Spine Surgery, Heart Market

Medical technology giant Medtronic has confirmed that 268 jobs have been cut in response to "sluggish market conditions" for heart defibrillators and spine devices, according to a Star Tribune news report.

New Technology Identifies and Treats Failing Prosthesis After Total Joint Replacement

A collaborative study between the Hospital for Special Surgery in New York City and the University of Nebraska Medical Center in Omaha has identified a new tool that detects when orthopedic prostheses are loosening after total joint replacement surgery, according…

K2M Receives 510(k) FDA Clearance for EVEREST System

K2M, a spinal device company, has received 510(k) clearance from the U.S. Food and Drug Administration to market its EVEREST Degenerative Spinal System, according to a company news release.

Wright Medical Group Announces Full Commercial Launch of FUSIONFLEX Scaffold

Wright Medical Group has launched its FUSIONFLEX Demineralized Moldable Scaffold, according to a company news release.

Johnson & Johnson's Synthes Takeover May Spur More Orthopedic Deals

Johnson & Johnson’s $21.3 billion acquisition of Synthes may drive its orthopedic device rivals Zimmer and Stryker to make their own deals, according to a report by Bloomberg.

Biomet Receives FDA Clearance for Articulation E1 Hip System

Biomet, a device company focused on the manufacturing of orthopedic products, has received FDA clearance for its Active Articulation E1 Dual Mobility Hip System, according to a company news release.

Johnson & Johnson to Acquire Synthes for $21.3B

Johnson & Johnson and Synthes have entered into a definitive agreement, in which Johnson & Johnson will acquire Synthes for $21.3 billion, according to a company news release.

Brookside Surgery Center Announces Participation in Personalized Knee Replacement Clinical Trial

Joseph Burkhardt, DO, of Brookside Surgery Center in Battle Creek, Mich., will be participating in a 10-year follow-up trial of the ConforMIS iUni G2 knee resurfacing device, according to a report from Genetic Engineering & Biotechnology News.